Echo Health Ventures, Cambia’s investment arm, recently announced their CEO Rob Coppedge has been selected as a judge of the Alexa Diabetes Challenge—a competition that looks to nurture comprehensive solutions that use Alexa’s voice technology to improve the lives of those with Type 2 Diabetes.
There are five finalists in the competition, which began in April. The challenge organizers were excited to add Rob’s wealth of experience getting innovative solutions to scale as a part of the run-up to Demo Day on Sept. 25 – the official unveiling of these innovative, new patient-centered solutions.
Read about Rob’s role supporting innovation in digital health on the Alexa Diabetes Challenge website.
The Challenge is sponsored by Merck & Co., Inc., Kenilworth, New Jersey, U.S.A., and supported by Amazon Web Services (AWS). The Challenge is powered by Luminary Labs.